Cardiac fibroblast activation detected by positron emission tomography/computed tomography as a possible sign of cardiotoxicity

Eur Heart J. 2020 Mar 1;41(9):1060. doi: 10.1093/eurheartj/ehz736.

Authors

Matthias Totzeck¹, Johannes Siebermair¹, Tienush Rassaf¹, Christoph Rischpler²

Affiliations

¹ Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Hospital Essen, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
² Department of Nuclear Medicine, University Hospital Essen, Medical Faculty, University of Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany.

PMID: 31630152
DOI: 10.1093/eurheartj/ehz736

No abstract available

MeSH terms

Cardiotoxicity*
Fibroblasts
Fluorodeoxyglucose F18
Heart
Humans
Positron Emission Tomography Computed Tomography*
Positron-Emission Tomography
Radiopharmaceuticals

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18